Hibsago, has been approved in the US, its second major market after Japan, giving patients hope of a functional cure without ...

While relatively uncommon, UC that starts in childhood tends to be more extensive and severe than when it emerges in ...

That one chance rests on a set of decisions about data and the systems that hold it. Those decisions are usually made quickly ...

US MFN rules and new tariffs are narrowing the US–ex-US price gap and drawing more manufacturing and capital investment toward the United States. Low European or UK list prices now directly affect US ...

A compounded version of Eli Lilly's injectable weight-loss and diabetes therapy tirzepatide, produced and sold by Apothecary ...

GSK's PD-1 inhibitor Jemperli has been cleared by the FDA as a pre-operative treatment for rectal cancer that can eliminate ...

Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a trial designed to expand the label of the recently approved drug failed.

AstraZeneca has launched a project with tech giant Oracle that will use AI and real-world data to improve clinical research, ...

Researchers in the US have developed an AI foundation model – trained on millions of facial images – that seems to be able to ...

A year after signing a first deal with Hansoh worth up to $1.45 billion, Roche has returned for another that could be more ...

Merck KGaA has reached a deal to acquire UK-based Silence Therapeutics in ​an all-cash, $1.3 billion deal that will boost its ...

Shah Capital has ended its attempts to exert influence over vaccine developer Novavax, bringing more than years of activism ...